Scott Hutton insider trades: Biodesix (BDSX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Scott reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | BDSX | ↓ Sell | 3,559 | $10.08 | $36K | Direct | Feb 11, 2026 (1d) |
| Jan 16, 2026 | BDSX | ↓ Sell | 970 | $8.15 | $8K | Direct | Jan 20, 2026 (4d) |
| Nov 10, 2025 | BDSX | ↓ Sell | 189 | $7.62 | $1K | Direct | Nov 13, 2025 (3d) |
| Aug 13, 2025 | BDSX | ↓ Sell | 3,772 | $0.42 | $2K | Direct | Aug 14, 2025 (1d) |
| May 13, 2025 | BDSX | ↓ Sell | 3,775 | $0.36 | $1K | Direct | May 13, 2025 (0d) |
| Feb 11, 2025 | BDSX | ↓ Sell | 83,660 | $0.92 | $77K | Direct | Feb 12, 2025 (1d) |
| Nov 12, 2024 | BDSX | ↓ Sell | 3,740 | $1.40 | $5K | Direct | Nov 13, 2024 (1d) |
| Aug 12, 2024 | BDSX | ↓ Sell | 3,744 | $1.59 | $6K | Direct | Aug 12, 2024 (0d) |
| May 9, 2024 | BDSX | ↓ Sell | 3,764 | $1.48 | $6K | Direct | May 10, 2024 (1d) |
| Feb 12, 2024 | BDSX | ↓ Sell | 64,390 | $1.80 | $116K | Direct | Feb 12, 2024 (0d) |
| Nov 10, 2023 | BDSX | ↓ Sell | 3,765 | $1.25 | $5K | Direct | Nov 13, 2023 (3d) |
| Aug 10, 2023 | BDSX | ↓ Sell | 13,782 | $1.33 | $18K | Direct | Aug 10, 2023 (0d) |
| May 10, 2023 | BDSX | ↓ Sell | 13,782 | $1.57 | $22K | Direct | May 10, 2023 (0d) |
| Feb 9, 2023 | BDSX | ↓ Sell | 16,278 | $1.80 | $29K | Direct | Feb 10, 2023 (1d) |
| Nov 10, 2022 | BDSX | ↓ Sell | 13,777 | $1.03 | $14K | Direct | Nov 10, 2022 (0d) |
| Aug 9, 2022 | BDSX | ↓ Sell | 13,634 | $2.53 | $34K | Direct | Aug 10, 2022 (1d) |
| May 10, 2022 | BDSX | ↓ Sell | 13,278 | $1.83 | $24K | Direct | May 11, 2022 (1d) |
| Nov 17, 2021 | BDSX | ↑ Buy | 3,000 | $6.46 | $19K | Direct | Nov 18, 2021 (1d) |
| Oct 30, 2020 | BDSX | ↑ Buy | 5,500 | $18.00 | $99K | Direct | Nov 3, 2020 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BDSX insiders
Open-market trades in the last 12 months
About Scott Hutton's insider trades
Scott Hutton is President & CEO at Biodesix (BDSX). Since Oct 30, 2020, Scott has reported 2 open-market purchases worth $118K and 17 sales worth $405K on SEC Form 4. In the last 12 months: 3 sales ($45K).
Their filings also include option exercises (18 filings), grants and awards (13 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BDSX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.